|
Cytarabine |
|
Retrospective analyses of cooperative group studies and a prospective randomized trial show that increasing the intensity of postremission therapy is beneficial in younger, but not older adults.3, 4, 49 Several studies have evaluated the role of intensive postremission consolidation with high-dose 3 gm m2 dose ; cytarabine HiDAC ; . A prospective study by the Cancer and.
Meredith M, Rabaglia ME, Metz SA. Evidence of a role for GTP in the potentiation of Ca2 + -induced insulin secretion by glucose in intact rat islets. J Clin Invest 1995; 96 2 ; : 811-21. Kowluru A. Adenine and guanine nucleotide-specific succinyl-CoA synthetases in the clonal beta-cell mitochondria: implications in the beta-cell high-energy phosphate metabolism in relation to physiological insulin secretion. Diabetologia 2001; 44 1 ; : 8994. Shenolikar S, Nairn AC. Protein phosphatases: recent progress. Adv Second Messenger Phosphoprotein Res 1991; 23: 1-121. Cohen P. The structure and regulation of protein phosphatases. Annu Rev Biochem 1989; 58: 453-508. Kowluru A, Metz SA. Purine nucleotide- and sugar phosphate-induced inhibition of the carboxyl methylation and catalysis of protein phosphatase-2A in insulin-secreting cells: protection by divalent cations. Biosci Rep 1998; 18 4 ; : 171-86. Sjholm , Lehtihet M, Efanov AM, Zaitsev SV, Berggren PO, Honkanen RE. Glucose metabolites inhibit protein phosphatases and directly promote insulin exocytosis in pancreatic beta-cells. Endocrinology 2002; 143 12 ; : 4592-8. Chalfant CE, Kishikawa K, Mumby MC, Kamibayashi C, Bielawska A, Hannun YA. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem 1999; 274 29 ; : 20313-7. Kowluru A, Metz SA. Ceramide-activated protein phosphatase 2A activity in insulinsecreting cells. FEBS Lett 1997; 137: 179-182. Sjholm . Ceramide inhibits pancreatic beta-cell insulin production and mitogenesis and mimics the actions of interleukin-1 beta. FEBS Lett 1995; 367 3 ; : 283-6. Erickson AK, Killilea SD. Effects of fructose 2, 6-bisphosphate and glucose 1, 6bisphosphate on porcine heart protein phosphatase 2A. Biochem Int 1992; 27 2 ; : 353-9. Cook GA, Gamble MS. Regulation of carnitine palmitoyltransferase by insulin results in decreased activity and decreased apparent Ki values for malonyl-CoA. J Biol Chem 1987; 262 5 ; : 2050-5. Cook GA. The hypoglycemic sulfonylureas glyburide and tolbutamide inhibit fatty acid oxidation by inhibiting carnitine palmitoyltransferase. J Biol Chem 1987; 262 11 ; : 4968-72. Onay-Besikci A, Campbell FM, Hopkins TA, Dyck JR, Lopaschuk GD. Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart. J Physiol Heart Circ Physiol 2003; 284 1 ; : H283-9. Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, Prentki M. Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic beta-cell line INS-1. J Biol Chem 1997; 272 3 ; : 1659-64.
Sisted only of trimethoprim-sulfamethoxazole, measures that are comparable to those used by other groups. Furthermore, while 0 1 s and other manifestations of progressive AIDS are frequent causes of death in such patients, most patients still die of progressive lymphoma. Of the 42 patients treated with low-dose m-BACOD plus intrathecal cytarabine by Levine et al, I5 21 50% ; died of progressive lymphoma, nine 21% ; died of AIDS-related complications, three 7% ; died of unknown causes, one 2% ; died ofbacterial sepsis, and one 2% ; committed suicide. Improved supportive care and antiviral therapy is unlikely to prolong the life of a patient with a clinically aggressive lymphoma involving extranodal sites that is refractory to treatment. Therefore, we feel that the improved survival observed in our study is attributable to treatment with a more effective antilymphoma regimen, rather than the expertise of our group in supporting HIV-infected patients. Two patients in our series had HTLV-I-related NHL. We elected to include these patients in our pilot study since the prognosis for these patients is also poor with standard chemotherapy, and since the course of their illness may also be complicated by OIS.'.~While no conclusions can be made regarding the efficacy of infusional CDE in these patients, our encouraging results in HIV-related NHL suggest that continued study is warranted in patients with HTLV-I-related NHL as well. No patient in our study died of an isolated CNS relapse. Only patients with diffuse, small noncleaved lymphoma or lymphomatous marrow involvement received prophylactic CNS therapy. Therefore, our findings suggest that restricting CNS prophylaxis to those specific groups may be a reasonable strategy. However, the development of lymphomatous meningitis in two patients despite prophylactic intrathecal MTX suggests the schedule used may not be effective in preventing CNS relapse; alternative options could include more frequent intrathecal MTX administration, alternation with or substitution by cytarabine, administration of systemic high-dose MTX, or perhaps earlier implementation of prophylactic WBRT. Fortunately, both patients with isolated CNS relapse.
Methionine resulted in a decrease in cobal amin levels in the liver and kidney relative to levels found in animals fed the correspond ing choline-adequate diets diets 1 vs. 7 and 2 vs. 8 ; . A decrease was also noted in the liver when choline was removed from a methionine-deficient, cobalamin-adequate diet diet 3 vs. 5 ; , whereas an increase was observed in the heart. The cobalamin levels of the liver, adrenals and heart were increased in animals receiving a diet triply deficient in choline, methionine and cobalamin com pared with levels found in animals fed a diet deficient only in methionine and cobalamin diet 4 vs. 6 ; . Methylcobalamin content.
Rgan donation after cardiac death is ing them to die at least partly for the pura big mistake for a host of reasons, poses of taking their organs. And in some not the least of which is that it's dri- protocols, physicians will start to preven mainly by the quest to get more or- serve the organs before the person is degans. This very nature of the practice clared dead. Not only is there unsettling geographmakes it inherently difficult to prevent conflict between donor and recipient in- ic and institutional variability in the application of donation after terests. cardiac death, but the whole People have a hard time as it concept--that you have to is in understanding the whole wait a certain amount of time notion of brain death and carto ensure the patient is actualdiac death--it's all very conly dead but not so long that the fusing. organs will not be viable--all As many see it, a person is eihas this kind of macabre sense ther dead or not dead. It's very to it. confusing, for instance, to see You simply cannot achieve a people on ventilators in an complete separation of the deICU, where they're warm to MICHAEL A. GRODIN, claration of death from the the touch, and be told that one M.D., is professor of is dead by the criteria of com- health law, bioethics, harvesting of organs with DCD, and it's a problematic plete, irreversible brain stem and human rights, blurring. and cortical death and the othBoston University The more we blur the two, er is not. School of Public It's also difficult, organ do- Health and professor, the more we risk treating patients as a means to an end, and nation aside, to understand the Boston University differences between declaring School of Medicine. the more disturbing and confusing it all becomes. death and discontinuing supAt Boston University's ethics port of other organs, or allowservice, I see all kinds of families who, ing a patient to die. In one case, the person is declared dead years later, believe they mistakenly alwithout any decisions being made or ac- lowed a loved one to die and allowed organs to be taken. They are morally distions taken by family members. The other case involves a decision for tressed over the decision. These issues are among those that are which family members can sometimes feel culpable and responsible, sometimes causing some hospitals to opt out of performing DCD. many years later. I believe that's the right thing to do. I These subtle and complicated issues become even more complicated--and the think that as a matter of public policy we blurring between life and death increases just shouldn't perform DCD. I would rather have fewer organs doexponentially--when donation after carnated and more certainty about death as diac death is involved. A discussion about organ procurement well as an honest, forthright, and transmust obviously occur before the person is parent system with no interface between dead because arrangements must be end-of-life care and organ donations. In addition to being ethically wrong, domade to go to the operating room to remove the ventilator and wait until the nation after cardiac death will cause a lack of trust in the organ procurement system heart stops. So you're talking about organ donation that, in the end, would only intensify the before the person is dead. You're allow- shortage of donor organs.
Buy cytarabine online
1811 cytarabine that overcomes some of the drawbacks of the parenterally administered compound. Following oral administration it is metabolised in the liver to active ara-C, and then is released into the circulation, resulting in plasma levels comparable to those achieved after low-dose parenteral cytarabine [12]. We explored the combination of interferon-a-2b and YNK01 in the setting of patients with newly diagnosed CML in a schedule mimicking the cytarabine arm of the French randomised controlled trial [9], with 10 days of YNK01 substituting for the parenteral cytarabine and cytomel.
[QUESTION INAUDIBLE] MR. SCHOENER: Yes, that is a good point. Leigh Buske is making the point that I think that basically probably is the size of the funding for the national highway system. To the extent that those dollars can be used for that purpose, it is a correct statement. But it is not solely for that purpose. Obviously the national highway system funds can be used for a whole range of activities. So perhaps we may want to burden the final document, make a slight editorial statement there, so it is understood that there isn't this billion specifically for land side. MS. GODWIN: The difficulty with asking for a dedicated source of funding is we might get a very small little pot. We might get, here is million for ports. And then when we go to our state or local government and ask for more than that they will say, you have your money over here. So if the dedicated source of funding is so small that it doesn't begin to meet our needs, and it cuts off our ability to compete under the other programs, we have probably done ourselves more harm than good. So it is balancing act.
Protein-protein interaction for functional characterization uses a state-of-the-art surface plasmon resonance SPR ; biosensor Biacore 3000 ; . A large number of publications appeared which used the SPR technique. The development of new surfaces for immobilization of analytes will widen the application range of the technique. Basically, SPR is based on the total internal reflection phenomenon. Changes in the mass concentration of macromolecules at a biospecific interface are recorded in real time, so that kinetic information is readily derived. Since the interaction takes place within the evanescent field close to an interface, one of the interactants has to be immobilized on the sensor surface. This procedure, although performed at very mild conditions may lead to inactivation. Maintaining the immobilized protein in an active state is a major issue. A number of different protein-protein interactions were studied, among which characterization of antibody fragments were the most successful. 107 and cytoxan.
Restoration of Profitability Early Profitability of U.S. Operations.
Cheap cytarabine online
For Physician P4P Measures. The resulting 16 measures now comprise the PVRP described above. It is expected that, as physicians register to participate in the PVRP and CMS gains experience in implementing the program, non-primary care measures will be added. This program is most likely a precursor to a pay-for-reporting program. Any such CMS program that impacts payment will require legislative action. The AGA Institute is pursuing two strategies for performance measures development: creating performance measures independently, as well as in conjunction with the AMA, as a lead organization. Our internal process is initially focused on creating measures related to polyp surveillance, performance of colonoscopy and hepatitis C management. See page 3 for more information on the newly released polyp surveillance measures. The AMA Consortium began its work around performance measures development in 2001. This physician-led initiative develops performance measures through select workgroups that include those with expertise in methodology and the clinical area under consideration, as well as other stakeholder representatives consumers, health plans and purchasers ; . The Consortium originally utilized a set of criteria for measures development to identify areas that fell mainly into the primary care arena. Over time, the process and criteria parameters have shifted to a focus on specialties and shared resources. As of November 2005, more than 100 individual performance measures in 16 content areas had been developed by the Consortium. In December 2005, the AMA Consortium co-chairs approved AGA Institute as the Lead Organization for the development of performance measures for Hepatitis C Management. Planning work has begun between the AGA Institute and the AMA Consortium staff for this initiative and the workgroup will meet and begin its work later in the year. Dr. Emmet Keeffe has been named by the Governing Board as AGA Institute's co-chair and dacarbazine.
Original articles Autologous peripheral blood progenitor cell transplantation mobilized with high-dose cytarabine in acute myeloid leukemia in first complete remission S. Pavlovsky, I. Fernandez, G. Milone, J. Martinez Rolon, C. Corrado, P. Desmery, C. Dignani, M. Michelet & M. Juni 151 High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia T. Karakas, U. Maurer, E. Weidmann, C.C. Miething, D. Hoelzer & L. Bergmann 159 Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institution J. Esteve, N. Villamor, D. Colomer, F. Bosch, A. Lopez-Guillermo, M. Rovira, A. Urbano-Ispizua, J. Sierra, E. Carreras & E. Montserrat 167 High-dose topotecan with granulocyte-colony stimulating factor in fluoropyrimidine-refractory colorectal cancer: A phase n and pharmacodynamic study E.K. Rowinsky, S.D. Baker, K. Burks, S. O'Reilly, R.C. Donehower & L.B. Grochow 173.
Skyepharma's proprietary depofoam tm ; delivery technology encapsulates cytarabine within minute lipid particles and daclizumab.
Description Performance parameter accumulation interval length--every 15 minutes Performance parameter accumulation interval length--starting from the last time the counters were cleared. This is only applicable to RMON-managed PMs.
A combination of mitoxantrone and cytarabine was successful in 50% to 60% of patients who experienced relapse after initially obtaining a complete remission and dactinomycin.
The K9 thrombin was defective in activating gel-filtered platelets, the EC50 value being equal to 38.6 6 nM in the mutant and 2.1 0.3 in WT form. In order to investigate the main causes of this impaired function, we studied the in vitro hydrolysis of the PAR1 38 60 peptide. This peptide bears both the sequence with the thrombin cleavage site and the domain interacting with the fibrinogen recognition exosite of the enzyme. In solution, this substrate showed a severe defect in interacting with K9, largely due to a decrease of the kcat value, as reported in Table II. The kcat Km value decreased 116 times from 1.74 107 M 1 s 1.5 105 M 1 s the mutant form, which corresponds at 25 C net decrease of 2.8 kcal mol in the activation free energy calculated on the basis of the ratio between the kcat and Km values. The interaction with immobilized GpIb was substantially unaffected by the mutation, the Kd values being similar in the two forms Table II ; . Thus, the defective platelet activating.
He museum will commemorate the life and legacy of Dr. Martin Luther King Jr. through stories, songs and tours. Visitors will experience the inspirational words of Dr. King as presented by actor Anthony Lucas; sing along with songs of peace and struggle, led by the Program in African American Culture Community Choir under the direction of Pam Rogers; and reflect on the achievements of Ralph Bunche, Nobel Prize recipient with curator Fath Davis-Ruffins. Visitors will also hear from participants in the 1951 Prince Edward County Virginia protest that became part of the Brown v. Board of Education; enjoy stories and songs of resistance that pre-date the Civil War and take interactive tours through the exhibition, "Separate Is Not Equal: Brown v. Board of Education and dalteparin.
Reconsolidation weeks 27-30 ; a ; Cyclophosphamide 1000 mg m2 IV over 20-30 minutes on day 29. Give 125mls m2 hr of Dextrose Saline infusion for 30 minutes before the cyclophosphamide and for 3.5 hours afterwards, i.e. 4 hours in total. Do not add potassium. Mesna is not needed. b ; Thioguanine TG ; . All patients receive TG 60 mg m2 day during delayed intensification 1. The drug is given daily by mouth for 14 days from day 29 beginning of week 27 ; to day 42 end of week 28 ; . Doses should be taken at least one hour after the evening meal, without milk products. Do not increase dose for neutrophils 2.0. Cytarabine 75mg m2 IV or SC days 30-33 four doses ; and 37-40 four doses ; . Vincristine 1.5mg m2 IV on days 43 and 50. PEG asparaginase 1000 units m2 IM on day 43. Intrathecal methotrexate on days 29 and 36. Dose by age: 2yrs: 8mg; 2yrs: or more: 12 mg.
Cytarabine is used to treat blood cancers acute non-lymphocytic leukemia , acute lymphocytic leukemia and chronic myelocytic leukemia and damiana!
Department of Health 2000 ; The NHS Plan. The.
Took up quarters in Dona Herlinda's house. A day later we made our formal visit to the curandera Mara Sabina, a woman made famous by the Wassons' publications. It had been in her hut that Gordon Wasson became the first white man to taste of the sacred mushrooms, in the course of a nocturnal ceremony in the summer of 1955. Gordon and Mara Sabina greeted each other cordially, as old friends. The curandera lived out of the way, on the mountainside above Huautla. The house in which the historic session with Gordon Wasson had taken place had been burned, presumably by angered residents or an envious colleague, because she had divulged the secret of teonancatl to strangers. In the new hut in which we found ourselves, an incredible disorder prevailed, as had probably also prevailed in the old hut, in which half-naked children, hens, and pigs bustled about. The old curandera had an intelligent face, exceptionally changeable in expression. She was obviously impressed when it was explained that we had managed to confine the spirit of the mushrooms in pills, and she at once declared herself ready to " serve us" with these, that is, to grant us a consultation. It was agreed that this should take place the coming night in the house of Doa Herlinda. In the course of the day I took a stroll through Huautla de Jimnez, which led along a main street on the mountainside. Then I accompanied Gordon on his visit to the Instituto Nacional Indigenista. This governmental organization had the duty of studying and helping to solve the problems of the indigenous population, that is, the Indians. Its leader told us of the difficulties that the "coffee policy" had caused in the area at that time. The president of Huautla, in collaboration with the Instituto Nacional Indigenista had tried to eliminate middlemen in order to shape the coffee prices favorably for the producing Indians. His body was found, mutilated, the previous June. Our stroll also took us past the cathedral, from which Gregorian chants resounded. Old Father Aragon, whom Gordon knew well from his earlier stays, invited us into the vestry for a glass of tequila and danaparoid.
Data systems records that cytarabine an cytarabine.
Substrate. Each data point is the average of five replicates. Standard deviations were plotted as error bars on each data points. C ; Solution binding assay for HA-HABP1: Fluorescence emission spectra of native 0.8M HABP1 excited at 295nm in the absence of HA curve1 ; , in the presence of 23M disaccharide equivalent of HA polysaccharide curve 2 ; difference of curve 1 and 2 curve 3 ; and 0.5 mg ml of HA polysaccharide curve 4 ; in 10 phosphate buffered saline pH 7.2. D ; Plot of relative fluorescence F F0 ; with increasing concentration of HA at different pH pH 4.5 open circle, pH 5.0 solid circle, pH 6.0 solid down triangle, pH6.5 open down triangle, pH7.2 solid square, and and dandelion and cytarabine.
Thus, the current riots display more than simplistic references to ChristianMuslim antagonism begin to articulate, for Islam in Nigeria has in fact come to symbolize the class conflict among Hausa Muslims as "an encompassing basis for social identity with sufficient internal differentiation to articulate conflicting interests in a complex society."143 The fact that Yan Izala members have been involved in frequent attacks on leaders of the Sufi brotherhoods clearly displays how controversial the application of shari'a law and the proliferation of other Islamic images are within the Muslim community itself. There is little doubt that the struggle to see shari'a courts reinstated in the northern Muslim states is more symbolic than substantive in relation to other religious groups, as witnessed by the fact that the laws will only apply to Muslims themselves. However, the conflict between different Muslim groups on the application is by no means merely symbolic, for the traditional `ulama have utilized its reinstatement as a carrot to the increasingly vocal Muslim opposition groups who have been attacking them for corruption and incompetence. The fervency of these attacks are witnessed by the rhetoric of the new Muslim intelligentsia, who often compare the current Muslim government in the northern states to the ancient pre-jihad Hausa empires claiming that "although the government elites would call themselves `Muslim, ' in reality they should be regarded as representatives of a system of jahiliyya and therefore should be fought in a second jihad if they do not consent to establish a truly Islamic state."144 Therefore, it is quite evident in the intellectual discourses stemming from the leaders of the Islamic movements engaged in the recent street violence, that the primary concern of Islamic reformers in Nigeria is change within the Islamic community rather.
Only 4 of the 13 ferrets reared with plugs had outer and middle right ears that looked clean and normal when inspected using an operating microscope Table 1 ; . A further 6 animals had pathology that appeared to be restricted to a partial or total occlusion of the external auditory meatus. These occlusions consisted of a constriction of the walls of the meatus, an accumulation of detritus in the meatal lumen, or both conditions. Two other ferrets 86-28, 86-32; Tables 1, 2 ; had, in addition to outer ear pathology, an accumulation of material in the middle ear. Clearing of the middle ear post mortem revealed an intact and normal-looking set of ossicles and cochlea. The auditory periphery of these 2 ferrets was examined in great detail Table 2 and dantrolene.
FILENAME Extravasation.DOC CONTROLLED DOC NO: Irritant Irritant Vesicant Irritant Non-Irritant Non-Irritant Non-Irritant Vesicant Vesicant Vesicant Vesicant Vesicant Vesicant Vesicant Vesicant Irritant Non-Irritant Non-Irritant Irritant Irritant Irritant Irritant Vesicant Irritant Non-Irritant Vesicant Non-Vesicant CCPG A12 Bleomycin Carboplatin Carmustine Cisplatin Crisantaspase Cyclophosphamide Cytarabine Dacarbazine Dactinomycin Daunorubicin Daunorubicin Liposomal ; Docetaxel Doxorubicin Doxorubicin Liposomal ; Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine Ifosfamide Irinotecan Methotrexate Mitomycin Mitoxantrone Oxaliplatin Paclitaxel Ralitrexed 2 BiCNU 2 Erwinase 1 Endoxana 1 DTIC 2 Actinomycin D 2 4 DaunoXome 2 Taxotere 3 4 Caelyx 2 4 Vepesid 2 Fludara 1 5FU 1 Gemzar 2 Mitoxana 2 Campto 2 4 Novantrone 2 Eloxatin 1 Taxol 3 Tomudex According to animal studies it may be classed as a non vesicant. Therefore group 1 Topotecan Hycamtin Irritant 2 Vinblastine Vesicant 3 Vincristine Vesicant 3 Vindesine Vesicant 3 Vinorelbine Navelbine Vesicant 3 ZD0473 Irritant 2 This drug has been placed in this group because of it's chemical similarity to Carboplatin and Cisplatin * IF A DRUG IS NOT LISTED CONTACT PHARMACY FOR THE RELEVANT INFORMATION.
Cytarabine injection alert Before they are used, vials from the following batches of Cytarabine 100mg ml solution for injection must be warmed to 55C for a maximum of 30 minutes, with adequate shaking, and then allowed to cool to room temperature Pharmacia ; : Batch number Expiry date Pack size U138G May 2003 10ml U191E May 2003 20ml The advice has been issued as a precautionary measure following reports of crystalline matter cytarabine ; present in vials. Pharmacia has submitted licence variations to include the above requirement for all future batches and also to amend the storage conditions to: Store at 15C to 25C. Further information can be obtained from medical information, Pharmacia tel 01908 661101.
Fig. 1. Probability of survival for all patients A ; and patients V60 years old B ; according to the dose of cytarabine in CALGB study 8525 7 ; . OnlyAML patients in CR who underwent postremission randomization are included. The P values are for the differences among the three treatment groups. The median follow-up was 52 months. Tick marks, surviving patients. Reprinted with permission from Mayer et al. 7.
Please note this is a simple guide illustrating which ELEY products are suitable for different applications. NB Some of our products may also be appropriate for other applications not shown above, this may depend on how Firearms are set up and maintained.
Vector, SCC-25 WT cells were transduced with either Ad.CMV- gal or Ad.CMV-dCK in vitro. Forty-eight hours later, the total RNA was harvested and analyzed for expression of the transgene. The SCC-25 cells transduced with Ad.CMV-dCK expressed high levels of dCK messenger RNA. In contrast, dCK expression was undetectable in Ad.CMV- galinfected cells Figure 3A ; . The level of dCK expression was dependent on the multiplicity of infection MOI ; Figure 3B ; . Cytotoxic assays were performed to determine whether SCC-25 transduction by Ad.CMV-dCK confers cytarabine sensitivity. Twenty-four hours after transduction, SCC-25 cells were exposed to various concentrations of cytarabine for 96 hours. The SCC-25 cells transduced by Ad.CMV- gal at different MOIs MOI 0, 20 ; showed no difference in sensitivity to cytarabine and cytomel.
By many factors-even a viral infection, renders it a particularly treacherous drug: a dosage that has produced therapeutic concentrations for a long period may inexplicably suddenly result in toxic levels. Of interest, phylline of the side in one of the recent reports in which theowas tested as an antianginal drug, one third subjects were excluded because of the drug's Although the spate angina ofthis of recent reports of use in treating into the actions pectoris may yield old drug, the body.
32. Kanis JA, McKloskey EV, O'Doherty D: Treatment of Paget's disease with the new bisphosphonates. In: Paget's disease of bone: clinical assesment present and future therapy. Edited by R. Singer and S. Wallach. New York: Elsevier; p. 112, 1991. 33. Reginster JY, Lecart MP, Deroisy R, et al: Prevention of postmenopausal bone loss by tiludronate. Lancet 2: 1469-71, 1989. Finley RS: Bisphosphonates in the treatment of bone metastases. Semin Oncol 29: 1328, 2002. Ralston SH: Pathogenesis and management of cancer associated hypercalcemia. Cancer Surv 21: 179-96, 1994. Rodan GA, Fleish HA: Bisphosphonates: mechanism of action. J Clin Invest 97: 2692-6, 1996. Fleisch H: Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs 42: 919-44, 1991. Green JR, Mller K, Jaeggi KA: Preclinical pharmacology of CGP 42'446, a potent, heterocyclic bisphosphonate compound. J Bone Miner Res 9: 745-51, 1994. Orr FW, Lee J, Duivenvoorden WCM, Singh G: Pathophysiologic interactions in Skeletal metastasis. Cancer 88: 2912-8, 2000. van der Pluijm G, Vloedgraven H, van Beek E, et al: Bisphosphonates inhibit the Adhesion of breast cancer cells to bone matrices in vitro. J Clin Invest 98: 698-705, 1996. Boissier S, Magnetto S, Frappart L, et al: Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res, 57: 3890-4, 1997. Wass JA, Varani J, Piontek GE, et al: Responses of normal and malignant cells to collagen, collagen-derived peptides and the C5-related tumor cell chemotactic peptide. Cell Differ 10: 329-32, 1981. Mundy GR, DeMartino S, Rowe DW: Collagen and collagen-derived fragments are chemotactic for tumor cells. J Clin Invest 68: 1102-5, 1981 Kusano K, Miyaura C, Inada M, et al: Regulation of matrix metalloproteinases MMP2, -3, -9, and -13 ; by interleukyn-1 and interleukyn-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology 139: 1338-45, 1998.
Well being 19: face-to-face visits with children objective: 90% federal standard ; number of children in number of children care at least one visited every month complete calendar month foster care 25 23 treatment 53 42 * outcome report changed effective november 2007!
Considerable progress has been made in the design of new and effective bisphosphonates. The original assumption that the mechanism of action of these compounds involved a strong physical interaction with the mineral phase only partially explains their action. It is now recognised that many of the effects result from interfering with essential cellular functions of osteoclasts. Some actions of the bisphosphonates can be separated, with different roles for the backbone and side chains of the molecule. In the future, it is probable that specific bisphosphonates will be produced that can target individual metabolic pathways within the cell to produce more bone-specific actions with less action on neighbouring cell types, reducing the occurrence of side effects.
|
|
|
